CDMO Avid Bioservices Inc

Avid Bioservices Inc is engaged in development and cGMP manufacturing of biopharmaceutical products derived from mammalian cell culture.

$18.05  +0.58 (3.32%)
As of 03/27/2023 14:09:48 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/11/2013
Outstanding shares:  62,547,056
Average volume:  966,474
Market cap:   $1,096,449,892
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BFMZ4W7

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%